Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

被引：508

作者：

Valle, J. W. ^{[1
]}

Borbath, I. ^{[2
]}

Khan, S. A. ^{[3
]}

Huguet, F. ^{[4
]}

Gruenberger, T. ^{[5
]}

Arnold, D. ^{[6
]}

机构：

[1] Univ Manchester, Inst Canc Sci, Christie NHS Fdn Trust, Dept Med Oncol, Manchester, Lancs, England

[2] Clin Univ St Luc, Dept Gastroenterol, Brussels, Belgium

[3] Imperial Coll, Dept Med, Hepatol & Gastroenterol Sect, London, England

[4] Univ Paris 06, Tenon Hosp, AP HP, Dept Radiat Oncol, Paris, France

[5] Rudolfstiftung Hosp, Dept Surg 1, Vienna, Austria

[6] Inst CUF Oncol ICO, Lisbon, Portugal

来源：

ANNALS OF ONCOLOGY | 2016年 / 27卷

关键词：

TRACT CANCER; EXTRAHEPATIC CHOLANGIOCARCINOMA; INTRAHEPATIC CHOLANGIOCARCINOMA; RISK-FACTORS; GEMCITABINE; CISPLATIN; CHEMOTHERAPY; EPIDEMIOLOGY; METAANALYSIS; MULTICENTER;

D O I：

10.1093/annonc/mdw324

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：v28 / v37

页数：10

共 45 条

[1] Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: A systematic review and pooled analysis [J].

Al-Adra, D. P. ;

Gill, R. S. ;

Axford, S. J. ;

Shi, X. ;

Kneteman, N. ;

Liau, S. -S. .

EJSO, 2015, 41 (01) :120-127

[2] Diagnosis and Management of Gallbladder Polyps [J].

Andren-Sandberg, Ake .

NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES, 2012, 4 (05) :203-211

[3]

[Anonymous], [No title captured]

[4] SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma [J].

Ben-Josef, Edgar ;

Guthrie, Katherine A. ;

El-Khoueiry, Anthony B. ;

Corless, Christopher L. ;

Zalupski, Mark M. ;

Lowy, Andrew M. ;

Thomas, Charles R., Jr. ;

Alberts, Steven R. ;

Dawson, Laura A. ;

Micetich, Kenneth C. ;

Thomas, Melanie B. ;

Siegel, Abby B. ;

Blanke, Charles D. .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (24) :2617-U57

[5] Gallbladder cancer: incidence and survival in a high-risk area of Chile [J].

Bertran, Enriqueta ;

Heise, Katy ;

Andia, Marcelo E. ;

Ferreccio, Catterina .

INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (10) :2446-2454

[6] EASL Clinical Practice Guidelines: Management of cholestatic liver diseases [J].

Beuers, Ulrich ;

Boberg, Kirsten M. ;

Chapman, Roger W. ;

Chazouilleres, Olivier ;

Invernizzi, Pietro ;

Jones, David E. J. ;

Lammert, Frank ;

Pares, Albert ;

Trauner, Michael .

JOURNAL OF HEPATOLOGY, 2009, 51 (02) :237-267

[7] MANAGEMENT STRATEGIES IN RESECTION FOR HILAR CHOLANGIOCARCINOMA [J].

BISMUTH, H ;

NAKACHE, R ;

DIAMOND, T .

ANNALS OF SURGERY, 1992, 215 (01) :31-38

[8]

Bosman FT, 2010, WHO Classification of tumors of the digestive system, V4th

[9]

Bragazzi MC., 2012, Translational gastrointestinal cancer, V1, P21, DOI [DOI 10.3978/J.ISSN.2224-4778.2011.11.04, 10.3978/j.issn.2224-4778.2011.11.04]

[10] Adjuvant gemcitabine plus docetaxel followed by 5FU chemoradiation for patients with resected pacreaticobiliary cancers: A single-institution, phase II study [J].

Cho, May Thet .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)

← 1 2 3 4 5 →